Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Frequency Therapeutics Inc
(NQ:
FREQ
)
0.3510
+0.0010 (+0.29%)
Streaming Delayed Price
Updated: 11:04 AM EDT, May 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
39,874
Open
0.3500
Bid (Size)
0.3510 (1)
Ask (Size)
0.3568 (3)
Prev. Close
0.3500
Today's Range
0.3500 - 0.3580
52wk Range
0.3500 - 5.590
Shares Outstanding
35,751,956
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Frequency Therapeutics: Q1 Earnings Insights
May 12, 2023
Via
Benzinga
Frequency Therapeutics Provides Business Updates and First Quarter 2023 Financial Results
May 12, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
Performance
YTD
-91.11%
-91.11%
1 Month
-7.66%
-7.66%
3 Month
-48.38%
-48.38%
6 Month
-83.29%
-83.29%
1 Year
-68.66%
-68.66%
More News
Read More
Stocks That Hit 52-Week Lows On Thursday
April 20, 2023
Via
Benzinga
Why Did Bullfrog AI Stock Jump More Than 50%?
April 05, 2023
Via
MarketBeat
Topics
Artificial Intelligence
Initial Public Offering
Exposures
Artificial Intelligence
Securities Market
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
March 21, 2023
Via
Benzinga
Frequency Therapeutics Provides Business Updates and Fourth Quarter and Full Year 2022 Financial Results
March 10, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
Frequency Therapeutics to Participate at Upcoming March Investor Conferences
February 27, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Thursday
February 16, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2023
February 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 14, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via
Benzinga
Dow Gains Over 300 Points; S&P 500 Up 1%
February 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
February 13, 2023
Via
Benzinga
Why Frequency Therapeutics Are Trading Lower By 82%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 13, 2023
Via
Benzinga
Nasdaq Rises 1.5%; G1 Therapeutics Shares Plummet
February 13, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
February 13, 2023
Via
Benzinga
Frequency Therapeutics' Lead Hearing Loss Program Flunks, Shifts Focus To Multiple Sclerosis, Shares Plunge
February 13, 2023
Via
Benzinga
US Stocks Open Higher; Dow Jumps 200 Points
February 13, 2023
Via
Benzinga
Frequency Therapeutics Announces Topline Results for its Phase 2b Study of FX-322 for the Treatment of Sensorineural Hearing Loss
February 13, 2023
From
Frequency Therapeutics, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 25, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 10, 2023
Via
Benzinga
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 10, 2023
Via
Benzinga
Frequency Therapeutics Announces Formation of Clinical Advisory Board for Remyelination in Multiple Sclerosis Program
December 19, 2022
From
Frequency Therapeutics
Via
Business Wire
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session
December 30, 2022
Via
Benzinga
Frequency Therapeutics Announces First Patient Dosed in Phase 1b Study of FX-345, the Company’s Second Therapeutic Candidate for Sensorineural Hearing Loss
December 15, 2022
From
Frequency Therapeutics, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.